February 3, 2024 Comments Off on New patent for Ocuphire drug RYZUMVI Posted in: Patent Added Annual Drug Patent Expirations for RYZUMVI Ryzumvi is a drug marketed by Ocuphire and is included in one NDA. The generic ingredient in RYZUMVI is phentolamine mesylate. Additional details are…
The post New patent for Ocuphire drug RYZUMVI appeared fir…
February 3, 2024 Comments Off on New patent for Alcon Labs drug EYSUVIS Posted in: Patent Added Annual Drug Patent Expirations for EYSUVIS Eysuvis is a drug marketed by Alcon Labs Inc and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent for Alcon Labs drug EYSUVIS appeared first on DrugPatentWatch …